Work

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Year: 2025

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.03.023

Authors: Paul Johannet, Matthew Flint, M. Herman Chui, Jason Konner, Claire Friedman, Angela K. Green, Robin Guo, Martee L. Hensley, Chrisann Kyi, Ying Liu, Vicky Makker, Maria Rubinstein, Paul Sabbatini, William P. Tew, Michael B. Foote, Britta Weigelt, Carol Aghajanian, Rachel N. Grisham, Roisin E. O’Cearbhaill

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: G7734538210, Cancer Center Support Grant

OpenAlex ID: W4408746410

FWCI: 2.713

Cites: 23

Cited by: 4

Related to: 10